|
1
|
Guillon MA, Mary PM, Brugière L,
Marec-Bérard P, Pacquement HD, Schmitt C, Guinebretière JM and
Tabone MD: Clinical characteristics and prognosis of osteosarcoma
in young children: A retrospective series of 15 cases. BMC Cancer.
11:4072011. View Article : Google Scholar :
|
|
2
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 Suppl 7:vii320–vii325. 2010. View Article : Google Scholar
|
|
3
|
Williams SA, Maecker HL, French DM, Liu J,
Gregg A, Silverstein LB, Cao TC, Carano RA and Dixit VM: USP1
deubiquitinates ID proteins to preserve a mesenchymal stem cell
program in osteosarcoma. Cell. 146:918–930. 2011. View Article : Google Scholar
|
|
4
|
Bacci G, Briccoli A, Rocca M, Ferrari S,
Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, et
al: Neoadjuvant chemotherapy for osteosarcoma of the extremities
with metastases at presentation: Recent experience at the Rizzoli
Institute in 57 patients treated with cisplatin, doxorubicin, and a
high dose of methotrexate and ifosfamide. Ann Oncol. 14:1126–1134.
2003. View Article : Google Scholar
|
|
5
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar
|
|
6
|
Benjamin RS: Osteosarcoma: Better
treatment through better trial design. Lancet Oncol. 16:12–13.
2015. View Article : Google Scholar
|
|
7
|
Letson GD and Muro-Cacho CA: Genetic and
molecular abnormalities in tumors of the bone and soft tissues.
Cancer Control. 8:239–251. 2001. View Article : Google Scholar
|
|
8
|
Haghikia A, Hoch M, Stapel B and
Hilfiker-Kleiner D: STAT3 regulation of and by microRNAs in
development and disease. JAKSTAT. 1:143–150. 2012.
|
|
9
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:(Database Issue).
D140–D144. 2006. View Article : Google Scholar
|
|
10
|
Namløs HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar :
|
|
11
|
Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang
Y, Zou C, Zhang X, Liu S, Wang X, et al: Analysis of MiR-195 and
MiR-497 expression, regulation and role in breast cancer. Clin
Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar
|
|
12
|
Li Z, Yu X, Shen J and Jiang Y: MicroRNA
dysregulation in uveal melanoma: A new player enters the game.
Oncotarget. 6:4562–4568. 2015. View Article : Google Scholar :
|
|
13
|
Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J
and Feng F: By downregulating TIAM1 expression, microRNA-329
suppresses gastric cancer invasion and growth. Oncotarget.
6:17559–17569. 2015. View Article : Google Scholar :
|
|
14
|
Li Z, Yu X, Shen J, Law PT, Chan MT and Wu
WK: MicroRNA expression and its implications for diagnosis and
therapy of gallbladder cancer. Oncotarget. 6:13914–13921. 2015.
View Article : Google Scholar :
|
|
15
|
Iorio MV and Croce CM: Causes and
consequences of microRNA dysregulation. Cancer J. 18:215–222. 2012.
View Article : Google Scholar :
|
|
16
|
Garzon R, Liu S, Fabbri M, Liu Z, Heaphy
CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, et al:
MicroRNA-29b induces global DNA hypomethylation and tumor
suppressor gene reexpression in acute myeloid leukemia by targeting
directly DNMT3A and 3B and indirectly DNMT1. Blood. 113:6411–6418.
2009. View Article : Google Scholar :
|
|
17
|
Fenger JM, Roberts RD, Iwenofu OH, Bear
MD, Zhang X, Couto JI, Modiano JF, Kisseberth WC and London CA:
MiR-9 is overexpressed in spontaneous canine osteosarcoma and
promotes a metastatic phenotype including invasion and migration in
osteoblasts and osteosarcoma cell lines. BMC Cancer. 16:7842016.
View Article : Google Scholar :
|
|
18
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar :
|
|
19
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumour Biol. 36:4357–4365. 2015. View Article : Google Scholar
|
|
20
|
Lou X, Qi X, Zhang Y, Long H and Yang J:
Decreased expression of microRNA-625 is associated with tumor
metastasis and poor prognosis in patients with colorectal cancer. J
Surg Oncol. 108:230–235. 2013. View Article : Google Scholar
|
|
21
|
Wang M, Li C, Nie H, Lv X, Qu Y, Yu B, Su
L, Li J, Chen X, Ju J, et al: Down-regulated miR-625 suppresses
invasion and metastasis of gastric cancer by targeting ILK. FEBS
Lett. 586:2382–2388. 2012. View Article : Google Scholar
|
|
22
|
Zhou X, Zhang CZ, Lu SX, Chen GG, Li LZ,
Liu LL, Yi C, Fu J, Hu W, Wen JM and Yun JP: miR-625 suppresses
tumour migration and invasion by targeting IGF2BP1 in
hepatocellular carcinoma. Oncogene. 34:965–977. 2015. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Zeng Q and Hong W: The emerging role of
the hippo pathway in cell contact inhibition, organ size control,
and cancer development in mammals. Cancer Cell. 13:188–192. 2008.
View Article : Google Scholar
|
|
25
|
Liu H, Li W, Chen C, Pei Y and Long X:
MiR-335 acts as a potential tumor suppressor miRNA via
downregulating ROCK1 expression in hepatocellular carcinoma. Tumour
Biol. 36:6313–6319. 2015. View Article : Google Scholar
|
|
26
|
Tu Y, Liu L, Zhao D, Liu Y, Ma X, Fan Y,
Wan L, Huang T, Cheng Z and Shen B: Overexpression of miRNA-497
inhibits tumor angiogenesis by targeting VEGFR2. Sci Rep.
5:138272015. View Article : Google Scholar :
|
|
27
|
Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC,
Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, et al: MicroRNA 135a
suppresses lymph node metastasis through down-regulation of ROCK1
in early gastric cancer. PLoS One. 9:e852052014. View Article : Google Scholar :
|
|
28
|
Li C, Li DC, Che SS, Ma K, Wang YJ, Xia
LH, Dai XM, Zhang GT, Shen Y, Jiao WJ and Tian KH: The decreased
expression of miR-625 predicts poor prognosis of esophageal
squamous cell carcinoma. Int J Clin Exp Med. 8:9560–9564. 2015.
|
|
29
|
Wang Z, Qiao Q, Chen M, Li X, Wang Z, Liu
C and Xie Z: miR-625 down-regulation promotes proliferation and
invasion in esophageal cancer by targeting Sox2. FEBS Lett.
588:915–921. 2014. View Article : Google Scholar
|
|
30
|
Zhou WB, Zhong CN, Luo XP, Zhang YY, Zhang
GY, Zhou DX and Liu LP: miR-625 suppresses cell proliferation and
migration by targeting HMGA1 in breast cancer. Biochem Biophys Res
Commun. 470:838–844. 2016. View Article : Google Scholar
|
|
31
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.
|
|
32
|
Orr BA, Bai H, Odia Y, Jain D, Anders RA
and Eberhart CG: Yes-associated protein 1 is widely expressed in
human brain tumors and promotes glioblastoma growth. J Neuropathol
Exp Neurol. 70:568–577. 2011. View Article : Google Scholar :
|
|
33
|
Lee KW, Lee SS, Kim SB, Sohn BH, Lee HS,
Jang HJ, Park YY, Kopetz S, Kim SS, Oh SC and Lee JS: Significant
association of oncogene YAP1 with poor prognosis and cetuximab
resistance in colorectal cancer patients. Clin Cancer Res.
21:357–364. 2015. View Article : Google Scholar
|
|
34
|
Kang W, Tong JH, Chan AW, Lee TL, Lung RW,
Leung PP, So KK, Wu K, Fan D, Yu J, et al: Yes-associated protein 1
exhibits oncogenic property in gastric cancer and its nuclear
accumulation associates with poor prognosis. Clin Cancer Res.
17:2130–2139. 2011. View Article : Google Scholar
|
|
35
|
Li S, Yu Z, Chen SS, Li F, Lei CY, Chen
XX, Bao JM, Luo Y, Lin GZ, Pang SY and Tan WL: The YAP1 oncogene
contributes to bladder cancer cell proliferation and migration by
regulating the H19 long noncoding RNA. Urol Oncol. 33(427): e1–10.
2015.
|
|
36
|
Zhang YH, Li B, Shen L, Shen Y and Chen
XD: The role and clinical significance of YES-associated protein 1
in human osteosarcoma. Int J Immunopathol Pharmacol. 26:157–167.
2013. View Article : Google Scholar
|
|
37
|
Yang Z, Zhang M, Xu K, Liu L, Hou WK, Cai
YZ, Xu P and Yao JF: Knockdown of YAP1 inhibits the proliferation
of osteosarcoma cells in vitro and in vivo. Oncol Rep.
32:1265–1272. 2014. View Article : Google Scholar
|
